NCT05844631

The Effects of the GOLO for Life® Plan and Release Supplement on Weight Management in Overweight and Obese Adults

An Open-label Study Evaluating the Effects of the GOLO for Life® Plan and Release Supplement on Weight Management in Overweight and Obese Adults

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 83 (actual)
• Sponsor: Golo · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to investigate the efficacy and safety of the GOLO for Life® Plan (G4LP) and Release supplementation on weight loss, body composition, and cardiometabolic parameters in overweight and obese adults. The change from baseline at Days 90 and 180 following the G4LP and supplementation with Release in weight (kg and % of total weight) and fat mass (percent and kg) will be assessed by Dual X-Ray Absorptiometry (DEXA). The weekly change in weight (kilograms and percent change) will also be assessed from baseline to day 180 following the G4LP and Release supplementation. Additionally, the safety and tolerability of the G4LP and Release supplementation will be measured by the occurrence of and/or changes in pre-emergent and post-emergent adverse events (AEs).

Conditions

• Obese
• Overweight

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Release	One capsule of Release will be taken three times per day for 180 days in combination with the G4LP.

Timeline

• Start date: 2023-04-20
• Primary completion: 2023-12-23
• Completion: 2023-12-23
• First posted: 2023-05-06
• Last updated: 2024-02-12

Locations

2 sites across 1 country: Canada